A Q4 2024 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+0.8% YoY

Gross Profit

$916M53.9% margin

Operating Income

$408M24.0% margin

Net Income

$351M20.6% margin

EPS (Diluted)

$1.22

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

$481M

Free Cash Flow

$388M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$11.8B

Total Liabilities

$5.9B

Stockholders' Equity

$5.9B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.7B	+0.8%
Gross Profit	$916M	$915M	+0.1%
Operating Income	$408M	$408M	+0.0%
Net Income	$351M	$475M	-26.1%

Revenue Segments

Life Sciences and Applied Markets

$833M49%

Diagnostics and Genomics

$442M26%

Agilent CrossLab

$426M25%

Geographic Segments

Americas

$680M40%

Asia Pacific

$567M33%

Europe

$454M27%